Please Join Us for An Interactive Virtual Town Hall Presentation! |
|
Faculty Joshua J. Neumiller, PharmD, CDCES, FASCP, FADCES |
Jennifer Trujillo, PharmD, FCCP, BCPS, CDCES, BC-ADM |
Heather P. Whitley, PharmD, BCPS, CDCES |
Goal |
|
Learning Objectives |
• |
Explain Explain the rationale for guideline recommendations on use of GLP-1 receptor agonists in patients with type 2 diabetes |
• |
Compare dosing, administration, clinical effects and tolerability of currently available GLP-1 receptor agonists |
• |
Discuss recent cardiovascular outcome trial (CVOT) findings with GLP-1 receptor agonists and implications in clinical practice |
UAN: 0430-0000-20-101-L01-P Credits: 1.25 hour (0.125 ceu) Duration: 75 minutes Location: From the convenience of your home or business; accessible via both PC and MAC Fee: There is no fee for this educational activity Target Audience: Pharmacists Type of Activity: Application |
|
Agenda |
|
Introduction (5 minutes) Presentation (60 minutes) Conclusions & Question & Answer Session (10 minutes) |
|
How to Earn Credit Participants must 1) read the learning objectives and faculty disclosures; 2) attend and participate in the live webinar; and 3) complete the evaluation form directly after the event with a maximum of within 60 days of attending the live session. To answer the questions, click on your selected choice for each answer then proceed to the next question. Your credit will automatically uploaded to CPE Monitor. |
Required Computer Hardware/Software |
|||||||||||||||||
|
|